Page 42 - Read Online
P. 42

Marasco et al. Hepatoma Res 2020;6:32  I  http://dx.doi.org/10.20517/2394-5079.2019.54                                        Page 11 of 17


               Interventional radiology
               Portal vein embolization (PVE) is an interventional radiological procedure. It consists of embolization of
               portal branches in the future resected liver, thus shifting blood flow to the FLR, allowing its hypertrophy
               before major hepatectomy. By increasing the volume of FLR, the risk for PHLF is decreased, even after
               extended liver resection [117] . Furthermore, preoperative PVE reduces intra-operative hepatocyte injury caused
               by the sudden increase in portal pressure at resection. Current guidelines recommend PVE for cirrhotic
               patients and an estimated FLR of ≤ 40%, or normal patients with an intended FLR of < 20% [150] .

               CT volumetry should be performed 3-4 weeks after PVE to assess the degree of hypertrophy, which if > 5%,
               is associated with improved patient outcomes [115] . A study by Capussotti et al. [151]  reported a FLR hypertrophy
               of 30%-40% in 4-6 weeks in more than 80% of patients, and was therefore able to prepare patients for
               hepatectomy after that period. Hepatic arterial buffer response, after reduction of portal blood flow post-
               PVE, can increase the size of the tumor. However, PVE preceded by trans-arterial chemoembolization
               (TACE) may prevent this by causing tumour necrosis [152] . RLE on Gd-EOB-DTPA-MRI has also been
               evaluated both pre- and post-PVE. In particular, the corresponding increase in RLE of the remnant liver
               at 14 and 28 days after PVE is significantly lower in patients who develop PHLF than in those who do not.
                                                                                                       [67]
               Similar results were found comparing patients without or with mild PHLF versus those with severe PHLF .
               CONCLUSION
               PHLF is still an event associated with major concerns by surgeons, especially in elderly patients. Several
               attempts have been made to identify the best non-invasive predictor of PHLF, in order to introduce a pre-
               operative tool for the assessment of such risk in routine clinical practice. Particularly, and when available,
               imaging parameters allow the identification of peri-operative risk factors related to the underlying cirrhosis,
               the volume of the liver remnant and patient related characteristics, mainly associated with the elderly such
               as sarcopenia and low bone mineral density. Otherwise, in other settings, LSM as well as ICG-r15 and the
               ALBI score are useful NITs able to mirror hepatic dysfunction and portal hypertension, and are thus being
               recommended before surgery for PHLF risk assessment. However, there is still poor evidence for their
               application in older patients. Further prospective and well-designed studies evaluating the ability of these
               NITs in predicting PHLF in the elderly are thus needed.


               DECLARATIONS
               Authors’ contributions
               Conceptualized and designed the review: Marasco G, Colecchia A
               Wrote, reviewed and edited the manuscript: Marasco G, Milandri M, Rossini B, Alemanni LV, Dajti E,
               Ravaioli F
               Provided the tables: Alemanni LV, Dajti E
               Reviewed and approved the final manuscript as submitted: Colecchia A, Renzulli M, Golfieri R, Festi D
               Read and approved the final manuscript: All authors

               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               None.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.
   37   38   39   40   41   42   43   44   45   46   47